With regard to rs12422149 and rs4149117, our findings were in contrast with the results published by Cho et al. in a minireview of the literature, where they concluded that genetic variants within the SLCO1B3 and SLCO2B1 genes were associated with prostate tumor development and progression [19]. The gene discussed is SLCO1B3; the disease is prostate neoplasm.